FDA Drug Recalls

Recalls / Class II

Class IID-0128-2019

Product

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Affected lot / code info
Lot: 757739, EXP 9/2020

Why it was recalled

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Recalling firm

Firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
900 Ridgebury Rd, N/A, Ridgefield, Connecticut 06877-1058

Distribution

Quantity
1,380 100-count bottles
Distribution pattern
Distributed nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2018-10-22
FDA classified
2018-11-01
Posted by FDA
2018-11-07
Terminated
2023-04-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0128-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls